Exosens Shares: New Gain of 2.71% Following Deal with Theon
The stock of the French specialist in electro-optical detection and imaging technologies closed at €49.30 on Tuesday, up 2.71% from the previous session. This upward movement comes in the wake of Theon International's entry into the capital.
Significant Gains Following Strategic Investment
Tuesday, October 14th, saw Exosens' stock rise by 2.71%, reaching €49.30 from €48 the previous day. This increase is part of a particularly strong momentum, with the stock having jumped 10.47% on Monday following the announcement of Theon International's acquisition of a 9.8% stake for €268.7 million, equivalent to €54 per share. Over the past week, the stock has shown a cumulative increase of 15.05%, while its quarterly performance has reached 20.24%. Today's trading volumes accounted for 0.4% of the capital, a moderate level reflecting relative stabilization after the high volatility observed the day before. Meanwhile, the CAC 40 declined by 0.18% to 7,919.62 points, highlighting the marked outperformance of the defense stock. Additionally, Deutsche Bank raised its price target for Exosens from €45 to €49 while maintaining its 'hold' recommendation. This revision is particularly based on the recent major contract win with the Spanish army for 17,000 next-generation night vision monoculars, scheduled for delivery between 2025 and 2028. The broker anticipates organic growth of 13% in the third quarter, driven by the amplification division, and expects revenues of €105.5 million for the period, representing an approximate 20% increase year-over-year. The quarterly revenue report is expected on October 27th.
Technical Breakthrough and Market Sentiment
Technically, on Tuesday, the stock broke through its previously identified resistance level at €48, a threshold that had capped earlier attempts to rise. This breakthrough, accompanied by a relative strength index at 60, indicates an active bullish momentum without immediately signaling overheating, as the RSI remains in the neutral zone. The stock is now significantly above its 50-day (€41.50) and 200-day (€35.52) moving averages, confirming the long-term bullish trend observed for several months. The significant gap between the current price and these averages highlights the extent of the progress made over the year, with a performance of 133.5% compared to 4.51% for the CAC 40 over the same period. The monthly volatility of the stock, measured at 15.55%, reflects the intensity of recent movements, although its beta of 0.06 indicates an extremely low sensitivity to variations in the Paris index. The Chaikin money flow, positive at 0.36, suggests that buying flows remain dominant, while the MACD displays a slightly positive histogram at 0.15, with the MACD line (1.30) above its signal line (1.15). The Bollinger Bands, ranging from €41.22 to €46.63, have been exceeded by the current price, indicating an extension of the bullish movement beyond usual statistical boundaries.
